CLINICAL_TRIALS
trial_result
· 2019-04-01
Clinical Trial Update: Treatment of Patients With RAD001 With Progressive Sarcoma [Phase 2]
Summary
Phase 2 trial evaluating RAD001 (everolimus) in patients with progressive sarcoma has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Progressive Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2019-04-01